Surgical Treatment of Oral Fibrous Hyperplasia with Diode Laser: An Integrative Review / Tratamiento Quirúrgico de la Hiperplasia Fibrosa Oral con Láser de Diodo: Una Revisión Integradora

This study aimed to carry out an integrative review of the use of diode lasers in the treatment of oral fibrous hyperplasia in order to observe surgical efficacy, healing process, and main microscopic findings. The following databases-PubMed/MEDLINE, Embase, Virtual Health Library, Scopus, Web of Science, and gray literature-were searched without regard to the time of year or language. Diode laser treatment cases described in case reports and case series were included, but those who did not undergo microscopic analysis to confirm the diagnosis or who did not provide postoperative information were excluded. Twelve studies (64 patients) were included. Prevalence was observed for females (68.75 %, n=44). In view of the diagnosis, there was a prevalence of focal fibrous hyperplasia (79.68 %, n=51), followed by inflammatory fibrous hyperplasia (20.31 %, n=13). For surgical removal, a diode laser was used with a wavelength ranging from 808 to 960 nm, in continuous mode, and an average power of 2830 mW. In general, there were no intercurrences in the trans and postoperative periods and wound healing occurred by second intention, with excellent evolution. High-powered diode lasers can be an excellent therapeutic option for oral hyperplastic lesions. Long-term clinical trials should be conducted to determine laser setting parameters in various oral lesions.

El objetivo de este estudio fue realizar una revisión integradora sobre el uso del láser de diodo en el tratamiento de la hiperplasia fibrosa oral, con el fin de visualizar la eficacia quirúrgica, el patrón de cicatrización y el análisis de los principales resultados microscópicos. Se realizó una búsqueda sin restricciones de año e idioma en PubMed/MEDLINE, Embase, Virtual Health Library, Scopus, Web of Science y literatura gris. Se incluyeron reportes de casos y series de casos que brindaron información sobre pacientes diagnosticados con lesiones hiperplásicas orales tratados con láser de diodo, excluyendo aquellos a los que no se les había realizado análisis microscópico para confirmar el diagnóstico, así como aquellos que no brindaron información postoperatoria. Se incluyeron doce estudios (64 pacientes). Se observó prevalencia en el sexo femenino (68,75 %, n=44). Ante el diagnóstico, predominó la hyperplasia fibrosa focal (79,68 %, n=51), seguida de la hiperplasia fibrosa inflamatoria (20,31 %, n=13). Para la remoción quirúrgica se utilizó un láser de diodo con una longitud de onda de 808 a 960 nm, en modo continuo, y una potencia promedio de 2830 mW. En general, no hubo intercurrencias en el trans y postoperatorio y la cicatrización de la herida ocurrió por segunda intención, con excelente evolución. El uso de láseres de diodo de alta potencia puede ser una excelente alternativa terapéutica para las lesiones hiperplásicas orales. Se deben realizar más estudios clínicos a largo plazo para determinar los parámetros de ajuste del láser en diferentes lesiones orales.

Effect of low-level LASER therapy versus CAD/CAM Michigan splint on patients with Temporomandibular Muscle Disorders: a randomized clinical trial / Efeito da terapia LASER de baixa potência versus placa de Michigan CAD/CAM em pacientes com Distúrbios Temporomandibulares musculares: um ensaio clínico randomizado

Objective: This study aimed to evaluate the efficacy and sustainability of using low level LASER therapy and CAD/CAM Michigan splint on improving the range of mandibular movements, muscle activity and reducing the pain. Material and Methods: 56 female patients were randomly divided into two groups. Group A: Patients received applications of low-level LASER therapy using semiconductor InGaAsp diode LASER type 940 nm with continuous mode of operation, applied for 180 sec per session for 12 sessions. Group B: Patients received Michigan splint of 2 mm thickness constructed on their upper teeth, the splint was 3D digitally printed. Electromyography was used to evaluate muscle activity, visual analogue scale was used to evaluate the pain intensity, ARCUS digma facebow was used to evaluate range of mandibular movements, and maximum mouth opening was taken using a millimeter ruler. They were measured before the beginning of the treatment, and at three and six month follow-up periods. Results: The results revealed that both low-level LASER therapy and Michigan splint reduce the myofascial pain, improved the range of the mandibular movements, and the muscles activity, but the effect of the low-level LASER therapy was more profound and sustainable. After 6 months from the beginning of the treatment, changes in masseter muscle activity (P= 0.001; effect size= 1.757), pain intensity (P= 0.003; effect size= 3), and range of mandibular movement (P= 0.001, effect size= 1.729) differed significantly between the two groups. Conclusions: Low-level LASER therapy had a better and more sustainable effect on reducing the pain intensity and improving the muscle activity as well as the mandibular movement when compared to Michigan splint (AU)

Objetivo: Este estudo teve como objetivo avaliar a eficácia e a durabilidade do uso da terapia LASER de baixa potência e da placa de Michigan CAD/CAM na melhora da amplitude dos movimentos mandibulares, atividade muscular e redução da dor. Material e Métodos: 56 pacientes do sexo feminino foram divididos aleatoriamente em dois grupos. Grupo A: os pacientes receberam aplicações de terapia LASER de baixa potência utilizando diodo semicondutor InGaAsp LASER tipo 940 nm em modo contínuo de operação, aplicado por 180 segundos por sessão durante 12 sessões. Grupo B: os pacientes receberam a placa de Michigan com uma espessura de 2 mm confeccionada sobre a arcada superior, a placa foi impressa digitalmente em 3D. A eletromiografia foi utilizada para avaliar a atividade muscular, a escala visual analógica foi utilizada para avaliar a intensidade da dor, o arco facial ARCUS digma foi utilizado para determinar a amplitude dos movimentos mandibulares e a abertura máxima da boca foi medida com uma régua milimétrica. Todas as medidas foram realizadas antes do início do tratamento e nos períodos de acompanhamento de três e seis meses. Resultados: Os resultados revelaram que tanto a terapia LASER de baixa potência como a placa de Michigan reduziram a dor miofascial, aumentaram a amplitude dos movimentos mandibulares e melhoraram a atividade muscular, mas o efeito da terapia LASER de baixa potência foi mais profundo e duradouro. Após 6 meses do início do tratamento, as alterações na atividade do músculo masseter (P= 0. 001; tamanho do efeito= 1,757), intensidade da dor (P= 0,003; tamanho do efeito= 3), e amplitude de movimento mandibular (P= 0,001, tamanho do efeito= 1,729) diferiram significativamente entre os dois grupos. Conclusão: A terapia com LASER de baixa potência teve um efeito melhor e mais duradouro na redução da intensidade da dor e na melhora da atividade muscular, bem como do movimento mandibular, quando comparada à placa de Michigan(AU)

Tratamiento quirúrgico de la hiperplasia prostática benigna: comparación entre enucleación láser, resección trans uretral y adenomectomía abierta

Objetivo: Comparar el resultado actual de tres técnicas quirúrgicas en pacientes intervenidos por Hiperplasia Benigna de Próstata (HPB); Enucleación láser de próstata (HoLEP), Resección transuretral (RTU) y Prostatectomía Abierta (PA). Enfermedad que actualmente presenta cambios en su presentación clínica y mayores comorbilidades al momento de la cirugía. Materiales y Método: Análisis retrospectivo de 1. 211 pacientes consecutivos e intervenidos en un mismo centro por HPB entre 2008 y 2017 y con al menos 6 meses de evaluación posoperatoria. Se registró las características periperatorias y comorbilidades, comparando los resultados intra y post operatorios obtenidos según la técnica quirúrgica empleada. Se realizó análisis uni y bivariados en programa SPSS versión 17. Para comparar variables categóricas empleamos test exacto de Fisher y para las variables continuas la prueba de Mann-Whitney. Resultados: Al momento de la cirugía 769 pacientes (63,5%) se encuentran en terapia médica por HPB, 268 (22,1%) presentan retención urinaria y 212 (17,5%) se encuentran en terapia anticoagulante-antiagregante. Se realizó HoLEP en 423 pacientes (36,9%), RTU en 651 (56,9%) y PA en 71 (6,2%). Aquellos intervenidos por HoLEP tienen significativa mayor frecuencia de terapia anticoagulante preoperatoria que RTU (9,2% v/s 4,9 %), manteniendo similar tasa de transfusión en post operatorio (0,5%). La mayor necesidad de transfusión la presentan los intervenidos por PA 5,6%. El tiempo de cateterismo y estadía hospitalaria es significativamente más breve en quienes se someten a HoLEP; 3,7 días v/s 4,4 en RTU y 7,1 en PA. También resultan determinantes del tiempo estadía hospitalaria la edad, presencia de cardiopatía coronaria y falla renal. Al sexto mes de la cirugía los pacientes intervenidos por HoLEP tienen un significativo mejor flujo urinario máximo y menor volumen residual. Conclusiones: En esta serie, los pacientes con HBP al momento de requerir cirugía presentan condiciones que se asocian a mayor tiempo de hospitalización: edad, cardiopatía coronaria y falla renal. Confirmamos que aquellos intervenidos con HoLEP registran una hospitalización significativamente más breve y resultados funcionales similares a RTU y PA.

Aim: To compare the current results of three surgical techniques in patients operated on for Benign Prostate Hyperplasia (BPH); Laser Enucleation of the Prostate (HoLEP), Transurethral Resection (TURP) and Open Prostatectomy (PA). Disease that currently presents changes in its clinical presentation and greater comorbidities at the time of surgery. Materials and Method: Retrospective analysis of 1211 consecutive patients operated on in the same center for BPH between 2008 and 2017 and with at least 6 months of postoperative evaluation. The periperative characteristics and comorbidities were recorded, comparing the intra- and post-operative results obtained according to the surgical technique used. A univariate and bivariate analysis was performed using SPSS version 17. To compare categorical variables, we used Fisher's exact test and the Mann-Whitney test for continuous variables. Results: At the time of surgery 769 patients (63.5%) were on medical therapy for BPH, 268 (22.1%) had urinary retention and 212 (17.5%) were on anticoagulant-antiplatelet therapy. HoLEP was performed in 423 patients (36.9%), TURP in 651 (56.9%) and PA in 71 (6.2%). Those operated on by HoLEP had a significantly higher frequency of preoperative anticoagulant therapy than TURP (9.2% vs. 4.9%), maintaining a similar transfusion rate postoperatively (0.5%). The greatest need for transfusion is presented by those operated on by AP 5.6%. The time of catheterization and hospital stay is significantly shorter in those who undergo HoLEP; 3.7 days v / s 4.4 in TUR and 7.1 in PA. Age, presence of coronary heart disease and kidney failure are also determinants of the length of hospital stay. At the sixth month after surgery, patients operated on by HoLEP had a significantly better peak urinary flow and lower residual volume. Conclusions: In this serie, patients with BPH at the time of requiring surgery, presents conditions that are associated with a longer hospitalization time: age, coronary heart disease and kidney failure. We confirmed that those who underwent HoLEP had a significantly shorter hospitalization and functional results, similar to TURP and AP

Vapoenucleación prostática con láser Tulio. ¿Es igual de segura y efectiva en pacientes ancianos? Análisis por puntuación de propensión de los resultados funcionales y perioperatorios tempranos / Is thulium laser vapoenucleation of the prostate equally safe and effective in elderly patients? A propensity score matched analysis of early perioperative and functional outcomes

Objetivo: Evaluar la seguridad y efectividad de la vapoenucleación prostática con laser Tulio (TuLEP) en una cohorte seleccionada de pacientes ancianos en comparación con pacientes «más jóvenes».Material y métodosSe realizó un análisis retrospectivo de los pacientes consecutivos que se sometieron a TuLEP entre septiembre de 2018 y febrero de 2020. Tras aplicar los criterios de inclusión/exclusión, los pacientes se estratificaron según el punto de corte de 75 años sugerido por la OMS: el grupo A incluyó a los pacientes < 75 años; el grupo B incluyó a los pacientes > 75 años.La evaluación preoperatoria incluyó una consulta con el urólogo, el valor del antígeno prostático específico (PSA), el International Prostate Symptom Score (IPSS) y quality of life (QoL), ecografía transrectal para estimar el volumen prostático (PVol) y uroflujometría para evaluar los valores preoperatorios de maximum urinary flow rate (Qmax) y average urinary flow rate (Qave), así como el volumen residual postmiccional (PVR). Se analizaron los datos perioperatorios y postoperatorios con un seguimiento de 3 meses.ResultadosTras el análisis de puntuación de propensión, 51 pacientes fueron emparejados 1:1 frente a otros 51 con base en PVol, PSA, Qmax, IPSS y QoL. Los pacientes eran comparables al inicio excluyendo la edad 65 (IQR 59-70) vs. 79 (IQR 77-82) años, Grupo A vs. grupo B, respectivamente (valor p < 0,001).No se encontraron diferencias en cuanto al descenso de la hemoglobina, la tasa de complicaciones, el tiempo de cateterismo y la duración de la estancia hospitalaria. Los pacientes del grupo A (más jóvenes) experimentaron una mejora significativamente mayor en cuanto al valor absoluto de Qmax, Qave y ΔQmax a los 30 días. A los 90 días de seguimiento, las diferencias entre los grupos desaparecieron.Durante los 90 días de seguimiento, no se encontraron diferencias significativas en la tasa de reingreso ni se requirieron reintervenciones. (AU)

Purpose: To evaluate if thulium laser vapoenucleation of the prostate (ThuVEP) is equally safe and effective in a selected cohort of elderly patients when compared to “younger” patients.Materials and MethodsWe performed a retrospective analysis of consecutive patients who underwent ThuVEP between September 2018 and February 2020. After application of the inclusion/exclusion criteria, patients were stratified according to the 75 years-old cut-off point suggested by the WHO. Group A included patients < 75 years-old; Group B included patients > 75 years-old.Preoperative assessment included urological consultation, prostate specific antigen (PSA), International Prostate Symptom Score (IPSS) and quality of life index, transrectal ultrasound to estimate prostate volume (PVol), and uroflowmetry to assess preoperative Qmax, Qave and post-void residual volume (PVR). Perioperative and postoperative data were analyzed during 3-month follow-up.ResultsAfter propensity-score analysis, 51 versus 51 patients were 1:1 matched according to PVol, PSA, Qmax, IPSS and QoL. Patients were comparable at baseline excluding age (65 (IQR 59-70) versus 79 (IQR 77-82) years, Group A versus B, respectively, p-value < 0.001).No differences were found in terms of hemoglobin drop, complications rate, catheterization time and length of hospital stay. Group A (younger) patients had more significant improvement in 30-days absolute Qmax, Qave and ΔQmax. At 90-days follow-up, the differences between the groups disappeared.Within the 90-days follow-up, no significant differences were found in the readmission rate, with no need of reinterventions. (AU)

Terapia láser transescleral de micropulsos en el manejo de los pacientes de glaucoma / MicroPulse® transscleral laser therapy in the management of glaucoma patients

Objetivo Evaluar la eficacia y seguridad de la terapia láser transescleral MicroPulse® (TLT) en el tratamiento de pacientes con glaucoma. Métodos Se llevó a cabo una serie de casos prospectiva, intervencionista y no comparativa en el Servicio de Oftalmología del Hospital Universitario Ain Shams en 61 ojos de 46 pacientes con diversos tipos de glaucoma y de gravedad, de leves a graves. Además de la agudeza visual mejor corregida, se registraron la presión intraocular (PIO) y el número de medicamentos para el glaucoma antes y después del tratamiento, junto con la necesidad postoperatoria de inhibidores sistémicos de la anhidrasa carbónica, las tasas de éxito, el número de sesiones de tratamiento y las complicaciones postoperatorias. El éxito se definió como una PIO de 6-18mmHg o una disminución de al menos el 30% de la PIO preoperatoria en ausencia de complicaciones que amenazaran la visión durante el periodo de seguimiento de 6 meses. Resultados Se realizó la TLT MicroPulse® en 61 ojos glaucomatosos. Se repitió la sesión de TLT MicroPulse® en 11 de los 61 ojos (18%) que no alcanzaron una PIO entre 6 y 18mmHg, o una disminución de al menos el 30% con respecto al valor inicial a los 6 meses. A los 6 meses de seguimiento tras una única sesión de TLT MicroPulse® la reducción media de la PIO fue del 35,9%±14,2%, y 6 meses después de la segunda sesión fue del 36,2%±17,5% (p<0,001). La tasa de éxito tras la primera sesión fue del 73,8%, que aumentó al 78,7% tras la segunda sesión. La reacción celular media de la cámara anterior fue de+1,9±0,8 al primer día,+1,0±0,7 a la primera semana y+0,2±0,4 al primer mes del postoperatorio. No se detectaron células en ninguno de los casos a los 3 y 6 meses de seguimiento (p<0,001). El número medio de colirios antiglaucomatosos antes del TLT MicroPulse® fue de 2,6±1,0 (AU)

Objective To evaluate the efficacy and safety of MicroPulse® transscleral laser therapy (TLT) in the management of glaucoma patients. Methods A prospective, interventional, non-comparative case series was conducted in the department of ophthalmology, Ain Shams University Hospital on 61 eyes of 46 patients with various glaucoma types and of severity, ranging from mild to severe. In addition to best-corrected visual acuity (BCVA), intraocular pressure (IOP) and the number of glaucoma medications were recorded before and after treatment, along with the postoperative need for systemic carbonic anhydrase inhibitors (CAI), success rates, number of treatment sessions and postoperative complications. Success was defined as an IOP of 6-18mmHg or at least a 30% decrease from preoperative IOP in the absence of any vision-threatening complications during the 6-month follow-up period. Results MicroPulse TLT was performed on 61 glaucomatous eyes. Eleven of the 61 eyes (18%) that did not achieve IOP between 6-18mmHg, or at least a 30% decrease from baseline at 6 months, had a repeat MicroPulse TLT session. At 6 months follow-up post a single MicroPulse TLT session, the mean IOP reduction was 35.9±14.2%; and 6 months after the second session, it was 36.2±17.5% (P<.001). The success rate after the first session was 73.8% which increased to 78.7% after the second session. The mean anterior chamber (AC) cell reaction was+1.9±.8 at 1 day,+1.0±.7 at 1 week, and+.2±.4 at 1 month postoperatively. No cells were detected in any of the cases at 3 and 6 months follow-up (P<.001). The average number of anti-glaucoma eye drops before MicroPulse TLT was 2.6±1.0. Postintervention, the average number of anti-glaucoma eye drops was 1.7±1.2, and sustained at 6 months follow-up after the last treatment session (P<.001). There were no significant complications were noted. One eye developed transient hypotony for 3 months after MicroPulse TLT (AU)

Is thulium laser vapoenucleation of the prostate equally safe and effective in elderly patients? A propensity score matched analysis of early perioperative and functional outcomes.

PURPOSE: To evaluate if thulium laser vapoenucleation of the prostate (ThuVEP) is equally safe and effective in a selected cohort of elderly patients when compared to "younger" patients. MATERIALS AND METHODS: We performed a retrospective analysis of consecutive patients who underwent ThuVEP between September 2018 and February 2020. After application of the inclusion/exclusion criteria, patients were stratified according to the 75 years-old cut-off point suggested by the WHO. Group A included patients ≤75 years-old; Group B included patients >75 years-old. Preoperative assessment included urological consultation, prostate specific antigen (PSA), International Prostate Symptom Score (IPSS) and quality of life index, transrectal ultrasound to estimate prostate volume (PVol), and uroflowmetry to assess preoperative Qmax, Qave and post-void residual volume (PVR). Perioperative and postoperative data were analyzed during 3-month follow-up. RESULTS: After propensity-score analysis, 51 versus 51 patients were 1:1 matched according to PVol, PSA, Qmax, IPSS and QoL. Patients were comparable at baseline excluding age (65 (IQR 59-70) versus 79 (IQR 77-82) years, Group A versus B, respectively, P-value <.001). No differences were found in terms of hemoglobin drop, complications rate, catheterization time and length of hospital stay. Group A (younger) patients had more significant improvement in 30-days absolute Qmax, Qave and ΔQmax. At 90-days follow-up, the differences between the groups disappeared. Within the 90-days follow-up, no significant differences were found in the readmission rate, with no need of reinterventions. CONCLUSIONS: In our hands, even in elderly patients affected by BPH, ThuVEP appears to be a safe and effective treatment option.

MicroPulse® transscleral laser therapy in the management of glaucoma patients.

PURPOSE: To evaluate the efficacy and safety of MicroPulse® transscleral laser therapy (TLT) in the management of glaucoma patients. METHODS: A prospective, interventional, non-comparative case series was conducted in the department of ophthalmology, Ain Shams University Hospital on 61 eyes of 46 patients with various glaucoma types and of severity, ranging from mild to severe. In addition to best-corrected visual acuity (BCVA), intraocular pressure (IOP) and the number of glaucoma medications were recorded before and after treatment, along with the postoperative need for systemic carbonic anhydrase inhibitors (CAI), success rates, number of treatment sessions and postoperative complications. Success was defined as an IOP of 6-18 mmHg or at least a 30% decrease from preoperative IOP in the absence of any vision-threatening complications during the 6-month follow-up period. RESULTS: MicroPulse TLT was performed on 61 glaucomatous eyes. Eleven of the 61 eyes (18%) that did not achieve IOP between 6-18 mmHg, or at least a 30% decrease from baseline at 6 months, had a repeat MicroPulse TLT session. At 6 months follow-up post a single MicroPulse TLT session, the mean IOP reduction was 35.9 ± 14.2%; and 6 months after the second session, it was 36.2 ± 17.5% (p < 0.001). The success rate after the first session was 73.8% which increased to 78.7% after the second session. The mean anterior chamber (AC) cell reaction was +1.9 ± 0.8 at 1 day, +1.0 ± 0.7 at 1 week, and +0.2 ± 0.4 at 1 month postoperatively. No cells were detected in any of the cases at 3 and 6 months follow-up (p < 0.001). The average number of anti-glaucoma eye drops before MicroPulse TLT was 2.6 ± 1.0. Postintervention, the average number of anti-glaucoma eye drops was 1.7 ± 1.2, and sustained at 6 months follow-up after the last treatment session (p < 0.001). There were no significant complications were noted. One eye developed transient hypotony for 3 months after MicroPulse TLT. CONCLUSIONS: MicroPulse TLT is safe and effective in lowering IOP in a variety of glaucoma types and severity.

Is thulium laser vapoenucleation of the prostate equally safe and effective in elderly patients? A propensity score matched analysis of early perioperative and functional outcomes. / Vapoenucleación prostática con láser Tulio. ¿Es igual de segura y efectiva en pacientes ancianos? Análisis por puntuación de propensión de los resultados funcionales y perioperatorios tempranos.

PURPOSE: To evaluate if thulium laser vapoenucleation of the prostate (ThuVEP) is equally safe and effective in a selected cohort of elderly patients when compared to "younger" patients. MATERIALS AND METHODS: We performed a retrospective analysis of consecutive patients who underwent ThuVEP between September 2018 and February 2020. After application of the inclusion/exclusion criteria, patients were stratified according to the 75 years-old cut-off point suggested by the WHO. Group A included patients < 75 years-old; Group B included patients > 75 years-old. Preoperative assessment included urological consultation, prostate specific antigen (PSA), International Prostate Symptom Score (IPSS) and quality of life index, transrectal ultrasound to estimate prostate volume (PVol), and uroflowmetry to assess preoperative Qmax, Qave and post-void residual volume (PVR). Perioperative and postoperative data were analyzed during 3-month follow-up. RESULTS: After propensity-score analysis, 51 versus 51 patients were 1:1 matched according to PVol, PSA, Qmax, IPSS and QoL. Patients were comparable at baseline excluding age (65 (IQR 59-70) versus 79 (IQR 77-82) years, Group A versus B, respectively, p-value < 0.001). No differences were found in terms of hemoglobin drop, complications rate, catheterization time and length of hospital stay. Group A (younger) patients had more significant improvement in 30-days absolute Qmax, Qave and ΔQmax. At 90-days follow-up, the differences between the groups disappeared. Within the 90-days follow-up, no significant differences were found in the readmission rate, with no need of reinterventions. CONCLUSIONS: In our hands, even in elderly patients affected by BPH, ThuVEP appears to be a safe and effective treatment option.

MicroPulse® transscleral laser therapy in the management of glaucoma patients. / Terapia láser transescleral de micropulsos en el manejo de los pacientes de glaucoma.

OBJECTIVE: To evaluate the efficacy and safety of MicroPulse® transscleral laser therapy (TLT) in the management of glaucoma patients. METHODS: A prospective, interventional, non-comparative case series was conducted in the department of ophthalmology, Ain Shams University Hospital on 61 eyes of 46 patients with various glaucoma types and of severity, ranging from mild to severe. In addition to best-corrected visual acuity (BCVA), intraocular pressure (IOP) and the number of glaucoma medications were recorded before and after treatment, along with the postoperative need for systemic carbonic anhydrase inhibitors (CAI), success rates, number of treatment sessions and postoperative complications. Success was defined as an IOP of 6-18mmHg or at least a 30% decrease from preoperative IOP in the absence of any vision-threatening complications during the 6-month follow-up period. RESULTS: MicroPulse TLT was performed on 61 glaucomatous eyes. Eleven of the 61 eyes (18%) that did not achieve IOP between 6-18mmHg, or at least a 30% decrease from baseline at 6 months, had a repeat MicroPulse TLT session. At 6 months follow-up post a single MicroPulse TLT session, the mean IOP reduction was 35.9±14.2%; and 6 months after the second session, it was 36.2±17.5% (P<.001). The success rate after the first session was 73.8% which increased to 78.7% after the second session. The mean anterior chamber (AC) cell reaction was+1.9±.8 at 1 day,+1.0±.7 at 1 week, and+.2±.4 at 1 month postoperatively. No cells were detected in any of the cases at 3 and 6 months follow-up (P<.001). The average number of anti-glaucoma eye drops before MicroPulse TLT was 2.6±1.0. Postintervention, the average number of anti-glaucoma eye drops was 1.7±1.2, and sustained at 6 months follow-up after the last treatment session (P<.001). There were no significant complications were noted. One eye developed transient hypotony for 3 months after MicroPulse TLT. CONCLUSIONS: MicroPulse TLT is safe and effective in lowering IOP in a variety of glaucoma types and severity.

Usos del láser en la terapia endodóntica: revisión de la literatura / Laser uses in endodontic therapy: literature review

Últimamente, el uso del láser en endodoncia ha ganado aceptación llegando a considerarse como un complemento a la terapia endodóntica, la cual tiene como objetivo realizar una efectiva conformación, limpieza y desinfección del sistema de canales radiculares (SCR), permitiendo una eliminación eficaz de microorganismos presentes, y así prevenir la reinfección del canal. Se han adoptado diferentes métodos de aplicación del láser para mejorar la desinfección del SCR, los cuales podrían ser eficaces para reducir la población microbiana presentes al interior de los canales, por medio de la activación del irrigante utilizado. El empleo de láser también podría ser útil en procedimientos endodónticos quirúrgicos los cuales tienen por objetivo mantener el diente y sus raíces cuando el tratamiento convencional ha fallado, los efectos positivos del láser se centrarían en el descenso de la inflamación y del aumento de volumen, además de la disminución de la filtración de los materiales de sello ortógrado en dientes apicectomizados. Otro de los usos de láser en esta materia está relacionado con el manejo del dolor post-terapia endodóntica, el que se ha visto ser prometedor. Se definen dos tipos de láseres: de baja potencia, que produce una acción bioestimulante, analgésica y antiinflamatoria de los tejidos biológicos, utilizada además en procesos de descontaminación del SCR, y de alta potencia o láser quirúrgico, con el que se pueden realizar incisiones, exéresis, realizando funciones de corte y coagulación.

Lately, the use of laser in endodontics has gained acceptance, being considered as a complement to endodontic therapy, which aims to carry out an effective shaping, cleaning and disinfection of the root canal system (RCS), allowing an effective elimination of microorganisms present, and thus prevent reinfection of the canal. Different laser application methods have been adopted to improve the disinfection of the RCS, which could be effective in reducing the microbial population present inside the canals, by activating the irrigant used. The use of laser could also be useful in surgical endodontic procedures which aim to maintain the tooth and its roots when conventional treatment has failed, the positive effects of laser would focus on reducing inflammation and increasing volume, in addition of the reduction in the filtration of orthograde seal materials in apicoectomized teeth. Another use of laser in this area is related to post-endodontic therapy pain management, which has shown promise. Two types of lasers are defined; low-power, which produces a biostimulant, analgesic and anti-inflammatory action of biological tissues, also used in RCS decontamination processes, and high-power or surgical laser, with which incisions, excision, performing cutting functions and coagulation.

Láser de baja potencia y aceleración de movimientos dentarios en ortodoncia: revisión sistemática / Low-level laser accelerating dental movements in orthodontics: systematic review

Según la literatura científica, ¿El láser de baja potencia propicia la aceleración de los movimientos dentarios durante el tratamiento ortodóntico? El objetivo de este trabajo buscasistematizar sobre la capacidad del láser de baja potencia en la aceleración de los movimientos dentarios durante el tratamiento ortodóncico. Para ello, se realizó una revisión sistemática, una búsqueda empleando buscadores booleanos en la plataforma de PubMed. Las palabras clave empleadas para fueron: orthodontic movement, orthodontic tooth movement, orthodontic, orthodontic treatment, low level laser therapy, low level laser,laser therapy y la combinación entre ellos. Las investigaciones incluidas trataron el tema de la aceleración del movimiento dentario durante el tratamiento de ortodoncia empleando láser de baja potencia. Se incluyeron en este estudio publicaciones de revistas indexadas en PubMed, ensayos clínicos, en idioma inglés y que correspondieran a artículos publicados desde el año 2000 a la fecha. A si también,se realizó evaluación del riesgo de sesgo. Las variables analizadas fueron: autor principal, título, año, tipo de artículo, revista, país de investigación y si los artículos demuestran que el láser de baja potencia aumenta el movimiento dentario durante el tratamiento ortodóncico. Los resultados arrojaron que el 60% de los estudios incluidos concluyen que el láser de baja potencia acelera el movimiento dentario durante el tratamiento de ortodoncia; el 30% de estos no encontraron cambios significativos con relación a los grupos estudiados con los de control y un 10% resultó en conclusiones dudosas. Por lo tanto, a pesar de que los resultados son alentadores por la tendencia en que el láser de baja potencia si acelera los movimientos ortodónticos, sería necesaria la presencia de un número superior de estudios clínicos aleatorizados para un esclarecimiento específico de las bondades que aporta esta terapia al sector.

According to scientific literature, does low-power laser promote acceleration of tooth movements during orthodontic treatment? The objective for this work seeksto systematize the ability of the low-power laser to accelerate tooth movements during orthodontic treatment.For this,a systematic review was carried out, a search using Boolean search engines on the PubMed platform. The keywords used for were: orthodontic movement, orthodontic tooth movement, orthodontic, orthodontic treatment, low level laser therapy, low level laser, laser therapy and the combination between them. The included investigations dealt with the issue of acceleration of tooth movement during orthodontic treatment using low-power laser, were from journals indexed in PubMed, clinical trials, in English, and corresponded to articles published since 2000 to date. Assessment of risk of bias was performed. The variables analyzed were: main author, title, year, type of article, journal, country of research, and whether the articles show that low-power laser increases tooth movement during orthodontic treatment.The results showed that 60% of the included studies conclude that the low-power laser accelerates tooth movement during orthodontic treatment, 30% of these did not find significant changes in relation to the groups studied with those of control and 10% resulted in dubious conclusions. Thus, although the results are encouraging due to the trend in which the low-power laser does accelerate orthodontic movements, the presence of a higher number of randomized clinical studies would be necessary for a specific clarification of the benefits that this therapy brings to the patient. sector.

mILIB: a new concept in laser therapy / mILIB: un nuevo concepto en laserterapia

mILIB (Intravascular Laser Irradiation in the Modified Bloodstream) presents itself as one more photobiomodulation technique, among the many therapeutic possibilities we know. The advantage in this case is the possibility of making application in a systemic way in which the organism as a whole is benefited. The use of the red therapeutic laser in a transcutaneous way, has been a great option as an added therapeutic value to the treatment of several pathologies, providing systemic stimuli, similar to hemotherapy. Thus, mILIB presents itself as an effective and increasingly widespread technique for professionals working with photobiomodulation

mILIB (Irradiación láser intravascular en el torrente sanguíneo modificado) se presenta como una técnica de fotobiomodulación más, entre las muchas posibilidades terapéuticas que conocemos. La ventaja en este caso es la posibilidad de realizar una aplicación de forma sistémica en la que se beneficia al organismo en su conjunto.El uso del láser terapéutico rojo de forma transcutánea, ha sido una gran opción como valor terapéutico añadido al tratamiento. de varias patologías, proporcionando estímulos sistémicos, similar a la hemoterapia. Así, mILIB se presenta como una técnica eficaz y cada vez más extendida para los profesionales que trabajan con fotobiomodulación.

Láser de baja potencia como coadyuvante en tratamiento endodóntico de pieza con reabsorción interna y lesión apical: reporte de un caso / Use of low level laser as an adjunct in endodontic treatment of teeth with internal resorption and apical lesión

La reabsorción radicular interna es infrecuente en dentición permanente, la mayoría de los casos se observan en dientes anteriores, su etiología no está del todo clara, es por esto que el tratamiento para este tipo de lesiones es la endodoncia. Se presenta el caso de una paciente sexo femenino, 38 años de edad, sin antecedes médicos relevantes, derivada para evaluación de diente 2.2 con mal pronóstico. El diagnóstico es de absceso apical agudo, pieza con reabsorción interna y lesión apical. Se realiza endodoncia con cementos biocerámicos y aplicación de láser terapéutico de 808 nm de longitud de onda, con parámetros específicos para acelerar la reparación del tejido óseo. La terapia de fotobiomodulación con láser de baja potencia parece ser útil como coadyuvante en el proceso de reparación ósea en piezas con lesión apical y reabsorción interna tratadas endodónticamente.

Internal root resorption is infrequent in permanent dentition, most cases are observed in anterior teeth, its etiology is not entirely clear, which is why the treatment for this type of lesion is endodontics.We present the case of a 38-year-old female patient, without relevant medical history, referred for evaluation of tooth 2.2 with a poor prognosis. Diagnosis Acute apical abscess, tooth with internal resorption and apical lesion. Endodontics are performed with bioceramic cements and the application of a 808 nm wavelength therapeutic laser, with specific parameters to accelerate bone tissue repair.Low-level laser photobiomodulation therapy appears to be useful as an adjunct in the bone repair process in endodontically treated teeth with apical lesion and internal resorption.

Nevus epidérmico verrucoso inflamatorio lineal: una revisión de la literatura / Inflammatory linear verrucous epidermal nevus: a review of the literature

El nevus epidérmico verrucoso inflamatorio lineal (NEVIL) es un tipo de nevus epidérmico queratinocítico, poco frecuente, de aparición predominante en la infancia, con preponderancia sobre el sexo femenino. Se caracteriza por la presencia de pápulas eritematosas descamativas de aspecto psoriasiforme, intensamente pruriginosas, que tienden a coalescer para formar placas que se distribuyen siguiendo las líneas de Blaschko. Suele presentarse de forma unilateral en extremidades inferiores y tiene pobre respuesta al tratamiento.

Inflammatory linear verrucous epidermal nevus (ILVEN) is a rare type of keratinocytic epidermal nevus that predominantly appears in childhood and female sex. It is characterized by the presence of psoriasiform, scaly, intensely itchy erythematous papules that tend to coalesce to form plaques that are distributed along Blaschko's lines. It usually affects the lower extremities unilaterally, and responds poorly to treatment.

Is low-level laser therapy (LLLT) effective in relieving the symptoms of temporomandibular disorders (TMDs)? A systematic review / ¿La terapia láser de bajo nivel (LLLT) es eficaz para aliviar los síntomas de los trastornos temporomandibulares (TTM)? Revisión sistemática

ABSTRACT Introduction: LLLT is used in various clinical situations for the relief of postoperative inflammatory symptoms in TMD cases. Many treatment protocols use laser radiation, but there is still no evidence as to whether one of them is superior to all the other. The objective was to establish whether there is evidence that LLLT can reduce the main symptoms of TMDs and to determine the most effective application protocol. Methods: a systematic review of the literature was performed in the main databases: PubMed, Scopus and Web of Science, by independent researchers who evaluated studies using different LLLT protocols to treat TMD symptoms, considering specific outcomes such as pain, mouth opening and jaw movements. Results: thirteen studies fully met the eligibility criteria. The most used laser type was GaAlAg, with a wavelength of 830 nm, number of applications ranging from 8 to 10, and 4 weeks of follow-up. Conclusions: LLLT may be considered as an alternative for the relief of TMD symptoms; however, scientific evidence of one of the protocols being superior to the others could not be found.

RESUMEN Introducción: la terapia láser de bajo nivel (LLLT por sus iniciales en inglés) se utiliza en diversas situaciones clínicas para el alivio de los síntomas inflamatorios posoperatorios en casos de trastornos temporomandibulares (TTM). Hay muchos protocolos de tratamiento que utilizan radiación láser, pero todavía no hay evidencia de que alguno sea superior a los demás. El objetivo de la presente revisión sistemática consistió en determiner si hay evidencia de que la LLLT pueda reducir los principales síntomas de los TTM y determinar el protocol de aplicación más eficaz. Métodos: se realizó una revisión sistemática de la literatura en las principales bases de datos, PubMed, Scopus y Web of Science, por parte de investigadores independientes que evaluaron los estudios utilizando diferentes protocolos de LLLT para tratar los síntomas de los TTM, considerando resultados específicos como dolor, apertura de la boca y movimientos de la mandíbula. Resultados: trece estudios cumplieron plenamente los criterios de elegibilidad. El tipo de láser más utilizado fue GaAlAg, con una longitud de onda de 830 nm, número de aplicaciones que oscilan entre 8 y 10, y 4 semanas de seguimiento. Conclusiones: la LLLT puede considerarse una alternativa para el alivio de los síntomas de los TTM; sin embargo, no se pudo encontrar evidencia científica de que un protocolo sea superior a los demás.

Effects of low-level laser on the repair of orthodontically induced inflammatory root resorption: a systematic review of studies in rats / Efectos del láser de bajo nivel en la reparación de la reabsorción radicular inflamatoria inducida por ortodoncia: una revisión sistemática de estudios en ratas

Orthodontically induced inflammatory root resorption (OIIRR) is a complication of dental treatment which consists of the degradation of local tissue due to an inflammatory reaction provoked by inappropriate orthodontic stimulus. The aim of the present systematic review was to assess the effectiveness of low-level laser therapy (LLLT) in reducing orthodontically induced inflammatory root resorption (OIIRR) in animal models. A systematic review was carried out in the MEDLINE, EMBASE and LILACS databases. Studies of interventions in animals were selected which analysed the effect of LLLT on OIIRR repair. The risk of bias was analysed through the 10 domains of the SYRCLE RoB tool for animal studies. Seventy-one studies were found; 27 were eliminated as duplicates and 44 titles/abstracts were analysed. Of these, 38 were excluded, and five studies were included for qualitative analysis. In 66.6 % of the studies included, the authors state that LLLT was effective in the inhibition/repair of OIIRR. In histological analysis it was observed that root resorption was significantly less in animals treated with laser as compared to the control. Furthermore, LLLT accelerated cicatrization after OIIRR. Laser proved effective in reducing root resorption lacunae and shortening the inflammatory process induced by the application of orthodontic force.

La resorción radicular inflamatoria inducida por tratamiento ortodontico (RRIITO) es una complicación del tratamiento odontológico que consiste en la degradación del tejido local debido a una reacción inflamación provocada por un estímulo ortodóntico inadecuado. El objetivo fue analizar la efectividad de la terapia láser de baja intensidad (LBI) en la disminución de RRIITO en ratas. Se realizó una revisión sistemática en las bases MEDLINE, EMBASE y LILACS. Fueron utilizados los términos 'resorción radicular', 'láser de baja intensidad', 'fototerapia', 'tratamiento ortodóntico', 'movimiento dental'. Fueron seleccionados estudios de intervención en animales, que analizaron el efecto del LBI en la reparación de la RRIITO. Los riesgos de sesgos fueron analizados mediante los 10 domínios de la herramienta SYRCLE RoB para estudios en animales. 71 estudios fueron encontrados, siendo eliminados 27 duplicados, y analizados 44 títulos/abstracts; de estos, fueron incluídos 5 estudios para análisis cualitativa. El 66,6 % de los estudios incluidos afirman que el LBI fue efectivo em reparar la RRIITO. En el análisis histológico se observó que la RRIITO fue significativamente menor en animales tratados con láser en comparación con el control. Además de eso, el LBI aceleró el proceso de cicatrización de la RRIITO. El láser se mostró efectivo en reducir las lagunas de resorción radicular y acortar el proceso inflamatorio inducido por la aplicación de fuerzas ortodonticas.

Laser Photobiomodulation in the acute inflammatory response of the calcaneal tendon injury in rats exposed to cigarette smoke / Fotobiomodulação Laser na resposta inflamatória aguda em lesão do tendão calcâneo em ratos expostos a fumaça de cigarro / Fotobiomodulación láser en la respuesta inflamatoria aguda en lesión del tendón calcáneo en ratones expuestos a humo de cigarrillo

ABSTRACT Nicotine delays the healing process and increases the levels of myeloperoxidase (MPO), an enzyme that plays a key role in the production of reactive oxygen species during the inflammatory process. Laser Photobiomodulation (PBM) is one of the most used electrophysical agents in the treatment of the calcaneal tendon, however, its effects on MPO activity need to be further elucidated. This study aimed to evaluate the effects of laser PBM on MPO activity after inflicting an injury to the calcaneal tendon of rats exposed to cigarette smoke. Thirty-four male Wistar rats with 90 days of age were used. After 14 days of exposure to cigarette smoke, the animals were divided into three experimental groups: control group (CG, n=12), not submitted to injury or treatment; sham group (ShG, n=10), submitted to partial calcaneal tendon injury and laser PBM simulation; and laser PBM group (PBMG, n=12), submitted to partial calcaneal tendon lesion and treated with laser PBM within the first minute after injury. PBM decreased MPO activity levels in PBMG compared to ShG (CG: 1.38±0.69pg/ml; ShG: 3.78±1.09pg/ml; PBMG: 2.58±0.93pg/ml; p<0.005). In conclusion, applying laser PBM immediately after inflicting damage to the calcaneal tendon attenuates acute inflammatory activity in rats exposed to cigarette smoke.

RESUMO A nicotina retarda o processo de cicatrização e eleva os níveis da enzima mieloperoxidase (MPO), a qual possui um papel fundamental na produção de espécies reativas de oxigênio durante o processo inflamatório. A fotobiomodulação laser (FBM) é um dos agentes eletrofísicos mais utilizados no tratamento do tendão calcâneo, no entanto, os seus efeitos sobre a atividade da MPO carecem de maior elucidação. Este estudo objetivou avaliar os efeitos da FBM sobre a atividade da MPO, após lesão do tendão calcâneo em ratos expostos à fumaça de cigarro. Foram utilizados 34 ratos Wistar, machos, com 90 dias de vida. Após 14 dias de exposição à fumaça de cigarro, os animais foram divididos em três grupos experimentais: grupo controle (GC, n=12), não submetido à lesão ou tratamento; grupo sham (GSh, n=10), submetido à lesão parcial do tendão calcâneo e a simulação da FBM laser; grupo FBM laser (GFBM, n=12), submetido à lesão parcial do tendão calcâneo e tratados com FBM laser, no primeiro minuto após a lesão. A FBM diminuiu os níveis de atividade da MPO no GFBM em comparação ao GSh (GC: 1,38±0,69 pg/ml; GSh: 3,78±1,09pg/ml; GFBM: 2,58±0,93pg/ml; p<0,005). Conclui-se que a FBM laser aplicada imediatamente após lesão do tendão calcâneo, atenua a atividade inflamatória aguda em ratos expostos à fumaça de cigarro.

RESUMEN La nicotina retarda el proceso de cicatrización y eleva los niveles de la enzima mieloperoxidasa (MPO), que tiene un papel fundamental en la producción de especies reactivas de oxígeno durante el proceso inflamatorio. La fotobiomodulación con láser (FBM) es uno de los agentes electrofísicos más utilizados en el tratamiento del tendón calcáneo, sin embargo sus efectos sobre la actividad de la MPO carecen de mayor elucidación. Este estudio objetivó evaluar los efectos de la FBM sobre la actividad de la MPO después de lesión del tendón calcáneo en ratones expuestos al humo de cigarrillo. Se utilizaron 34 ratones Wistar, machos, con 90 días de vida. Después de 14 días de exposición al humo de cigarrillo, los animales fueron divididos en tres grupos experimentales: grupo de control (GC, n=12), no sometido a la lesión o tratamiento; grupo sham (GSh, n=10), sometido a la lesión parcial del tendón calcáneo y a la simulación de la FBM láser; y el grupo FBM láser (GFBM, n=12), sometido a la lesión parcial del tendón calcáneo y tratado con FBM láser, en el primer minuto después de la lesión. La FBM disminuyó los niveles de actividad de MPO en el GFBM en comparación con el GSh (GC: 1,38±0,69 pg/ml; GSh: 3,78±1,09pg/ml; GFBM: 2,58±0,93pg/ml, p<0,005). Se concluye que la FBM láser aplicada inmediatamente después de la lesión del tendón calcáneo atenúa la actividad inflamatoria aguda en ratones expuestos al humo de cigarrillo.

Terapia láser de baja potencia en el acné vulgar / Low potency laser therapy in Acne vulgaris

RESUMEN Introducción: el acné es una enfermedad multifactorial que afecta en estructura y función a la unidad pilosebácea. Se presenta en los adolescentes y se padece mundialmente. En los casos más severos, puede involucrar al grupo familiar en su esfera afectiva y económica. La terapia láser de baja potencia se ha empleado como opción de procedimiento médico alternativo para el tratamiento de esta enfermedad; por su acción antibacteriana, antiedematosa y estimulante del sistema inmunitario. Objetivo: determinar el comportamiento del acné vulgar en pacientes con terapia láser de baja potencia. Materiales y métodos: se realizó un estudio descriptivo, prospectivo, en pacientes con formas clínicas leves y moderadas de acné vulgar que acudieron a la consulta de Dermatología del Hospital Universitario Comandante "Faustino Pérez Hernández", provincia Matanzas, entre junio del 2015 a junio del 2016. Se estudiaron las variables: edad, sexo, color de la piel, nivel de escolaridad, clasificación del acné, número de lesiones inflamatorias por hemicara, su tamaño, respuesta al tratamiento y grado de satisfacción. Se procesaron en el paquete estadístico SPSS para Windows, versión 16.0. Resultados: la mayor frecuencia de presentación fue de 18-25 años, sexo femenino y raza blanca. Respuesta satisfactoria independiente a su clasificación, con 15 sesiones, dos veces por semana. Conclusiones: el láser de baja potencia mejora y acorta el tiempo de evolución del acné vulgar.

ABSTRACT Introduction: acne is a multifactor disease that affects the structure and function of the pilosebaceous unit. It is a global condition that starts during adolescence. It can involve the family in its affective and economic sphere in the most severe cases. Low-power laser therapy is used as an alternative medical procedure for the treatment of this disease due to its antibacterial, antiedematous and immune-stimulant action. Objective: to determine the behavior of acne vulgar in patients under low potency laser therapy. Materials and methods: a descriptive, prospective study was carried out in patients suffering mild and moderated clinical forms of acne vulgaris who assisted the Dermatology consultation of the University Clinico-surgical Hospital "Faustino Perez Hernandez"¨, Matanzas province, from June 2015 to June 2016. The studied variables were age, sex, race, scholarship, acne classification, number of inflammatory lesions per hemiface, lesson size, answer to treatment and satisfaction level. Data were processed with the SPSS statistical package, 16.0 version for Windows. Results: the highest presentation frequency was in people aged 18-25 years, of the female sex and white race. The answer was satisfactory independently to classification with 15 sessions, twice a week. Conclusion: low potency laser improves and reduces acne vulgaris evolution time.

Terapia láser de baja frecuencia en el manejo del dolor en pacientes con osteonecrosis mandibular / Low level laser therapy in the management of pain in patients with osteonecrosis of the jaw

La terapia láser de baja frecuencia (TLBF) o fotobioestimulación es aquella que cuya luz provoca la regeneración y remodelación ósea, la restauración de la función neural, la disminución del dolor y la modulación del sistema inmune; esta terapia es un coadyuvante junto a la terapia conservadora y/o quirúrgica. Se considera un estándar de oro para el manejo del dolor en la osteonecrosis en aquellos pacientes que consumen o han consumido bifosfonatos como terapia para inhibir la resorción ósea. La Sociedad Americana de Investigación de Hueso y Minerales (SAIHM) definió la osteonecrosis mandibular como «un área de hueso expuesto en la región maxilofacial que no cicatriza dentro de las ocho semanas posteriores a la identificación, en un paciente que está recibiendo o ha estado expuesto a bifosfonatos y que no ha recibido radioterapia en la región craneofacial¼. En este reporte presentamos dos casos de pacientes con osteonecrosis mandibular relacionada a bifosfonatos tratados con TLBF. Se evaluó el dolor antes y después de la terapia con la escala visual análoga (EVA). Ambos casos tuvieron disminución del dolor al 100%. Se presentan los métodos de diagnóstico clínico y radiográfico, el tratamiento elegido y los resultados obtenidos (AU)

Low level laser therapy (LLLT) or photobiostimulation is one whose light causes bone regeneration and remodeling, restoration of neural function, reduction of pain, and modulation of the immune system; this therapy is an adjuvant together with conservative and / or surgical therapy. It is considered a gold standard for pain management in osteonecrosis in those patients who consume or have used bisphosphonates as antiresorptive therapy. The American Society for Bone and Mineral Research (ASBMR) defined osteonecrosis of the jaw as «an area of exposed bone in the maxillofacial region that does not heal within eight weeks after identification by a health care provider, in a patient who was receiving or had been exposed to a BP and who has not received radiation therapy to the craniofacial region¼. In this report we present two cases of patients with mandibular osteonecrosis related to bisphosphonates treated with LLLT. Pain before and after visual analogue scale (VAS) was evaluated. Both cases had pain reduction at 100%. The methods of clinical and radiographic diagnosis, the treatment chosen and the results obtained are presented (AU)

Terapia láser de baja potencia en el acné vulgar / Low potency laser therapy in Acne vulgaris

RESUMEN Introducción: el acné es una enfermedad multifactorial que afecta en estructura y función a la unidad pilosebácea. Se presenta en los adolescentes y se padece mundialmente. En los casos más severos, puede involucrar al grupo familiar en su esfera afectiva y económica. La terapia láser de baja potencia se ha empleado como opción de procedimiento médico alternativo para el tratamiento de esta enfermedad; por su acción antibacteriana, antiedematosa y estimulante del sistema inmunitario. Objetivo: determinar el comportamiento del acné vulgar en pacientes con terapia láser de baja potencia. Materiales y métodos: se realizó un estudio descriptivo, prospectivo, en pacientes con formas clínicas leves y moderadas de acné vulgar que acudieron a la consulta de Dermatología del Hospital Universitario Comandante "Faustino Pérez Hernández", provincia Matanzas, entre junio del 2015 a junio del 2016. Se estudiaron las variables: edad, sexo, color de la piel, nivel de escolaridad, clasificación del acné, número de lesiones inflamatorias por hemicara, su tamaño, respuesta al tratamiento y grado de satisfacción. Se procesaron en el paquete estadístico SPSS para Windows, versión 16.0. Resultados: la mayor frecuencia de presentación fue de 18-25 años, sexo femenino y raza blanca. Respuesta satisfactoria independiente a su clasificación, con 15 sesiones, dos veces por semana. Conclusiones: el láser de baja potencia mejora y acorta el tiempo de evolución del acné vulgar (AU).

ABSTRACT Introduction: acne is a multifactor disease that affects the structure and function of the pilosebaceous unit. It is a global condition that starts during adolescence. It can involve the family in its affective and economic sphere in the most severe cases. Low-power laser therapy is used as an alternative medical procedure for the treatment of this disease due to its antibacterial, antiedematous and immune-stimulant action. Objective: to determine the behavior of acne vulgar in patients under low potency laser therapy. Materials and methods: a descriptive, prospective study was carried out in patients suffering mild and moderated clinical forms of acne vulgaris who assisted the Dermatology consultation of the University Clinico-surgical Hospital "Faustino Perez Hernandez"¨, Matanzas province, from June 2015 to June 2016. The studied variables were age, sex, race, scholarship, acne classification, number of inflammatory lesions per hemiface, lesson size, answer to treatment and satisfaction level. Data were processed with the SPSS statistical package, 16.0 version for Windows. Results: the highest presentation frequency was in people aged 18-25 years, of the female sex and white race. The answer was satisfactory independently to classification with 15 sessions, twice a week. Conclusion: low potency laser improves and reduces acne vulgaris evolution time (AU).